Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study.

Objective: The comparative neuroprotective effects of different antidiabetes drugs have not been characterized in randomized controlled trials. Here, we investigated the therapeutic effects of liraglutide, dapagliflozin, or acarbose treatment on brain functional alterations and cognitive changes in...

Full description

Bibliographic Details

Published in:	Diabetes Care Vol. 45; no. 5; pp. 1201 - 1211
Main Authors:	Cheng, Haiyan, Zhang, Zhou, Zhang, Bing, Zhang, Wen, Wang, Jin, Ni, Wenyu, Miao, Yingwen, Liu, Jiani, Bi, Yan
Format:	diagnostic images research tables/charts randomized controlled trial Journal Article
Published:	American Diabetes Association May2022
Online Access:	View this record in EBSCOhost